Butyric acid, an inhibitor of the enzyme deacetylase (HDAC), can inhibit deacetylation to cause acetylation of the transcription factor NF-κB, thereby attenuating NF-κB-mediated systemic inflammatory response syndrome. Here, NFKB1 is linked to systemic inflammatory response syndrome.